SecBot SecBot
SECBOTREPLAY Home › Report › TEVA

TEVA · Multiple Teva executives, including the CEO, CFO, and other C-suite…

TEVA PHARMACEUTICAL INDUSTRIES LTD · CLUSTER filed Feb 25, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Feb 25, 2026 at 19:00 ET

Multiple Teva executives, including the CEO, CFO, and other C-suite officers, exercised stock options and received share grants in a routine compensation-related cluster. EVP Matthew Shields conducted open-market sales totaling $547.7K, representing full disposal of shares acquired through option exercises. All other transactions were non-cash events related to equity compensation.

  • EVP Matthew Shields sold 17,295 shares for $547.7K in open-market transactions following option exercises.
  • CEO Francis Richard D, CFO Kalif Eliyahu Sharon, and other executives exercised options and received share grants totaling over 300,000 shares, all non-cash events.
  • All transactions except Shields' sale were non-cash (codes M, A) and part of standard equity compensation execution.
  • Total open-market sales in cluster: $547.7K, representing 0.0015% of Teva's $35.7B market cap, negligible relative to company size.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access